A Phase 1, Single-centre, Double-blind, Randomized, Placebo-controlled, Two-cohort, Two-period Crossover Study of the Hemodynamic Interactions Between Avanafil and Two alpha-Adrenergic Blockers, Doxazosin and Tamsulosin, in Middle-aged Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 06 Jan 2011
At a glance
- Drugs Avanafil; Doxazosin; Tamsulosin
- Indications Benign prostatic hyperplasia; Erectile dysfunction; Hypertension
- Focus Pharmacodynamics
- Sponsors VIVUS
- 06 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Apr 2010 New trial record